Legend Biotech (LEGN) Total Current Liabilities (2019 - 2025)

Legend Biotech has reported Total Current Liabilities for 7 years, with the latest figure at $636.4 million in Q4 2025.

• For the quarter ending Q4 2025, Total Current Liabilities rose 129.17% year-over-year to $636.4 million; the trailing twelve-month figure through Dec 2025 stood at $636.4 million (up 129.17% YoY), and the FY2025 full-year result was $636.4 million, up 129.17% from the prior year.
• Total Current Liabilities for Q4 2025 stood at $636.4 million, up from $433.6 million in the prior quarter.
• The five-year high for Total Current Liabilities was $636.4 million in Q4 2025, with the low at $145942.0 in Q1 2021.
• Historically, Total Current Liabilities has averaged $251.2 million across 5 years, with a median of $243.9 million in 2023.
• Annual changes were most pronounced in 2021 — Total Current Liabilities jumped 222831.14% — and 2023, when it decreased 27.32%.
• Legend Biotech's Total Current Liabilities stood at $229.2 million in 2021, then grew by 29.92% to $297.8 million in 2022, then dropped by 27.32% to $216.4 million in 2023, then increased by 28.32% to $277.7 million in 2024, then soared by 129.17% to $636.4 million in 2025.
• The last three Total Current Liabilities figures came in at $636.4 million (Q4 2025), $433.6 million (Q3 2025), and $265.5 million (Q2 2025), per Business Quant data.